Position in EYPT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,151,329
+$1,026,130 QoQ
Shares Held
500,093
+5.2% QoQ
Ownership
0.580%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#37
of 188 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Derivatives in EYPT
reported options exposure · as of Dec 31, 2025CallValue
$685,125
CallShares
37,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,596,585,112 across 322 Biotechnology names. EYPT ranks #143 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in EYPT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,151,329 | 500,093 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,125,199 | 475,190 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $685,125 | 37,500 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $10,166,688 | 556,469 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,878,688 | 483,054 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $358,982 | 38,149 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $166,936 | 30,800 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,324,182 | 446,199 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $5,052,229 | 580,716 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $42,299,873 | 2,046,438 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $924,400 | 40,000 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $26,082,824 | 1,128,638 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,639,225 | 580,629 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,948,838 | 338,947 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,796,863 | 611,178 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,364,015 | 675,433 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,245,362 | 410,286 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,701,165 | 343,223 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,886,469 | 155,265 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,508,004 | 123,203 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $387,655 | 37,203 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,519,012 | 502,671 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,967,288 | 292,056 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $163,078 | 24,784 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $42,547 | 55,984 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $511,428 | 501,400 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||